GAMMA PHAGE LYSIS ASSAY FOR THE IDENTIFICATION OF BACILLUS ANTHRACIS

Bacteriophage And Controls, B. Anthracis Lysis

OFFICE OF THE SURGEON GENERAL, U.S. ARMY

The following data is part of a premarket notification filed by Office Of The Surgeon General, U.s. Army with the FDA for Gamma Phage Lysis Assay For The Identification Of Bacillus Anthracis.

Pre-market Notification Details

Device IDK051794
510k NumberK051794
Device Name:GAMMA PHAGE LYSIS ASSAY FOR THE IDENTIFICATION OF BACILLUS ANTHRACIS
ClassificationBacteriophage And Controls, B. Anthracis Lysis
Applicant OFFICE OF THE SURGEON GENERAL, U.S. ARMY 1436 PORTER STREET OFFICE OF REGULATORY AFFAIRS Fort Detrick,  MD  21702
ContactDiane Ullman
CorrespondentJulie Villaneuva
Centers For Disease Control Nad Prevention 1600 Clifton RD NE MS H24-11 Atlanta,  GA  30329
Product CodeNVQ  
CFR Regulation Number866.3045 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received2005-07-01
Decision Date2005-08-16

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.